R. Hogan
Pressure Medical,
United States
Keywords: Prolonged Field Care, Smart Pneumatic Tourniquet, Junctional Hemorrhage Control
Summary:
Overview: Pressure Medical is a Utah-based, veteran-founded medical device company established by a Navy hospital corpsman with deep expertise in combat casualty care. The company has developed proprietary smart pneumatic tourniquet technology protected by four issued US patents (2022-2025) with one additional patent pending, demonstrating significant innovation maturity and intellectual property strength. Core Technology & Innovation: Our flagship product is a smart pneumatic junctional tourniquet system featuring automated pressure control and integrated sensor technology. Unlike traditional manual tourniquets that require expert judgment for proper application, this device intelligently manages compression force through real-time feedback mechanisms. This critical innovation addresses junctional hemorrhage—injuries to the limbs. Exsanguination/hemorrhage represents the #1 preventable cause of battlefield death, accounting for approximately 24% of potentially survivable combat casualties. The smart automation eliminates human error, maintains optimal hemostatic pressure for 6+ hours without intervention, and prevents both under-pressurization (continued bleeding) and over-pressurization (tissue damage leading to unnecessary amputation). Military Strategic Alignment: The technology perfectly addresses urgent Department of Defense priorities, specifically the paradigm shift toward Prolonged Field Care (PFC) doctrine. Modern military operations in contested environments anticipate casualty evacuation delays of 96+ hours, requiring hemorrhage control devices that function autonomously with minimal medical supervision. Extended-use tourniquets have historically saved 1,000-2,000 US military lives, yet junctional injuries remain a persistent capability gap. Pressure Medical’s solution directly fills this gap while supporting Multi-Domain Battle and Large-Scale Combat Operations requirements. Commercial Market Opportunity: Beyond military applications, the global pneumatic tourniquet market demonstrates substantial commercial growth, expanding from $355.9 million (2021) to projected $3.2 billion+ by 2034, representing a 7.2% compound annual growth rate. Multiple revenue streams exist across industrial safety (mining, offshore drilling, forestry), emergency medical services, public access bleeding control initiatives, and orthopedic surgical applications. This dual-use positioning significantly strengthens the company’s investment profile and long-term sustainability. TechConnect 2026 Submission Strategy: Pressure Medical will submit three complementary abstracts targeting different symposia and stakeholder audiences: 1. Military-Focused Abstract: “Smart Pneumatic Junctional Tourniquet for Prolonged Field Care in Multi-Domain Operations” targeting the Biomaterials & Medical Devices symposium, emphasizing DoD strategic alignment and capability gap resolution. 2. Commercial-Focused Abstract: “Field-Ready Smart Tourniquet for Industrial Accident Hemorrhage Control in Remote Environments” demonstrating dual-use value and substantial civilian market opportunity. 3. Innovation Challenge Entry: “Smart Tourniquet Platform for Autonomous Combat Casualty Care Systems” positioning the company at the intersection of emerging technologies (AI, autonomous systems, robotics) and military medical innovation. Regulatory & Commercialization Readiness: The FDA 510(k) clearance pathway is well-established with precedent—the SAM Junctional Tourniquet received FDA clearance in 2013 and is currently fielded by the US Army. Pressure Medical’s technology positions for rapid regulatory approval while the company’s veteran-owned small business status unlocks federal contracting advantages. Strategic Significance: Pressure Medical represents the convergence of critical military medical need, proven innovation, favorable market timing, dual-use applications, and clear regulatory pathways—positioning the company perfectly for TechConnect World 2026 as a breakthrough technology capable of simultaneously saving lives on battlefields and in remote civilian environments globally.